Search results
Author(s):
Harriette Van Spall
,
Luke Laffin
Added:
10 months ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial…
View more
Author(s):
Eugenio B Reyes
,
Julian Alexander A Huibonhoa
,
Rogelio V Tangco
,
et al
Added:
9 months ago
Author(s):
Raja Ezman Raja Shariff
,
Mohd Afiq Hannan Mohd Azri
,
Burhanuddin Moize
,
et al
Added:
2 years ago
Polypill in Heart Failure Survey
Author(s):
Raja Ezman Raja Shariff
,
Khairul Shafiq Ibrahim
,
Sazzli Kasim
Added:
1 year ago
Article
Author(s):
Nazneem Wahab
,
Neranga Samaratunge
,
Dulaanga Rathnayake
Added:
6 months ago
Author(s):
Rena Winant
,
Sunu Budhi Raharjo
,
Rina Ariani
,
et al
Added:
1 year ago
Hypertension in Asia-Pacific
Author(s):
Raja Ezman Raja Shariff
,
Haowen Jiang
,
Jonathan Yap
,
et al
Added:
1 year ago
Article
Author(s):
Dyah Wulan Anggrahini
,
Detty Siti Nurdiati
,
Anggoro Budi Hartopo
,
et al
Added:
3 months ago
Author(s):
Chak-yu So
,
Leo Kar Lok Lai
,
Ling Na Wong
,
et al
Added:
1 year ago
Author(s):
Hanselim Lim
,
Wuri Noviar Hamdani
Added:
1 year ago